Efavirenz Capsule
Product Images NDC 65862-105

Product Visual Gallery

This gallery contains 29 technical images submitted to the FDA as part of the official labeling for Efavirenz (NDC 65862-105). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Efavirenz Fig1)

An illustration showing a hand holding a spoon over a small bowl containing a substance, with labeled containers of grape jelly, apple sauce, and yogurt in the background. The image appears to depict mixing or administering medication with food substances for ease of consumption.*

FDA Label Image

Figure 10 (Efavirenz Fig10)

An instructional illustration showing a hand pouring a liquid from a container into a spoon held by the other hand above a small bowl. The image appears to depict a step in medication preparation or administration.*

FDA Label Image

Figure 11 (Efavirenz Fig11)

An illustration showing three Efavirenz capsules of different strengths (50 mg, 100 mg, and 200 mg) aligned vertically. The diagram indicates that the capsules are positioned with overlapping ends to represent combined dosing.*

FDA Label Image

Figure 12 (Efavirenz Fig12)

Illustration showing two hands holding a capsule above a bowl of liquid, demonstrating the process of opening or handling the capsule.*

FDA Label Image

Figure 13 (Efavirenz Fig13)

An instructional diagram showing hands holding a capsule above a small bowl, with arrows indicating the capsule should be opened or separated, suggesting a method to empty its contents into the bowl.*

FDA Label Image

Figure 14 (Efavirenz Fig14)

An instructional illustration depicts hands opening a capsule, releasing its contents into a small bowl below. Two curved arrows indicate the capsule halves being separated to empty the powder inside.*

FDA Label Image

Figure 15 (Efavirenz Fig15)

An instructional illustration showing two hands opening a capsule and emptying its powder contents into a small bowl. This diagram likely demonstrates how to prepare the drug for further processing or administration.*

FDA Label Image

Figure 16 (Efavirenz Fig16)

An instructional illustration depicting a clock with a shaded 30-minute segment and an arrow, accompanied by text advising to finish dosing within 30 minutes.*

FDA Label Image

Figure 17 (Efavirenz Fig17)

An instructional illustration labeled Figure Q showing a hand stirring a powder or solid in a small cup with a spoon, demonstrating a mixing process.*

FDA Label Image

Figure 18 (Efavirenz Fig18)

An instructional line drawing shows a hand holding a syringe with the thumb positioned on the plunger, indicating how to hold and operate the syringe. The drawing is labeled as 'Figure R'.*

FDA Label Image

Figure 19 (Efavirenz Fig19)

An instructional line drawing showing a hand holding a syringe being dipped into a bowl or container, demonstrating a step of liquid preparation or drawing up medication. The figure is labeled as 'Figure S' and is related to handling or processing drug products.*

FDA Label Image

Figure 2 (Efavirenz Fig2)

An illustration depicting three capsule dosage forms of Efavirenz in 50 mg, 100 mg, and 200 mg strengths. The figure shows how overlapping capsules correspond to the different strengths, visually linking the 50 mg, 100 mg, and 200 mg dosages arranged vertically.*

FDA Label Image

Figure 20 (Efavirenz Fig20)

An instructional illustration depicting a hand using a syringe to draw liquid from a small bowl. The image shows the proper technique for this action, intended for guidance in medication preparation or administration.*

FDA Label Image

Figure 21 (Efavirenz Fig21)

An instructional illustration showing administration of medication to a child using an oral device. The image depicts a hand holding a small oral syringe or dropper near the child's open mouth for direct delivery of the medicine.*

FDA Label Image

Figure 22 (Efavirenz Fig22)

An illustration depicting two circular arrows in a loop, displayed next to the text 'Step 4, Step 10, Step 11.' The figure is labeled as Figure V. No additional context or detailed instructions are visible.*

FDA Label Image

Package Label-principal Display Panel (50 mg (30 Capsule Bottle))

Label for Efavirenz Capsules USP 50 mg, a drug for further processing in capsule form by Aurobindo Pharma Limited. The label shows a 30-capsule count, with storage instructions from 20° to 25°C and the distributor as Aurobindo Pharma USA, Inc. It includes an alert about medicines that should not be taken with Efavirenz Capsules.*

FDA Label Image

Package Label-principal Display Panel (50 mg Blister Carton (3 x 10 Unit-dose))

Packaging label for Efavirenz Capsules USP 50 mg by Aurobindo Pharma Limited. The label indicates a bottle containing 30 capsules (3 x 10 unit-dose). It includes dosage strength, pharmacist alert information, barcode, distributor details, and storage instructions.*

FDA Label Image

Package Label-principal Display Panel (100 mg (30 Capsule Bottle))

Label for Efavirenz Capsules USP 100 mg, a drug for further processing in capsule form. The label displays the NDC number 65862-105-30 and indicates a package size of 30 capsules. It states the active ingredient strength as 100 mg of efavirenz USP per capsule and notes storage conditions. The label is from Aurobindo Pharma Limited, distributed by Aurobindo Pharma USA, Inc.*

FDA Label Image

Package Label-principal Display Panel (100 mg Blister Carton (3 x 10 Unit-dose))

Packaging label for Efavirenz Capsules USP 100 mg by Aurobindo Pharma Limited. The label displays the product name, strength (100 mg), dosage form (capsules), and package size (30 capsules in 3 x 10 unit-dose). It includes a red alert regarding medicines that should not be taken with Efavirenz and storage instructions. The label also shows the NDC 65862-105-10 and distributor information for Aurobindo Pharma USA, Inc.*

FDA Label Image

Package Label-principal Display Panel (200 mg (30 Capsule Bottle))

Packaging label for Efavirenz Capsules USP, 200 mg strength, in capsule form. The label indicates 30 capsules per package and is distributed by Aurobindo Pharma USA, Inc. Directions note to see package insert for dosage, and storage instructions specify 20° to 25°C. An alert warns against taking certain medicines with Efavirenz Capsules USP.*

FDA Label Image

Package Label-principal Display Panel (200 mg Blister Carton (3 x 10 Unit-dose))

Packaging label for Efavirenz Capsules USP 200 mg by Aurobindo Pharma Limited. The label shows 30 capsules (3 x 10 unit-dose) with dosage strength prominently displayed. Includes an alert box advising to find out about medicines that should not be taken with Efavirenz Capsules. The label also contains storage instructions, pharmacy coverage instructions, and distributor information for Aurobindo Pharma USA, Inc.*

FDA Label Image

Figure 3 (Efavirenz Fig3)

An instructional line drawing labeled Figure C showing two hands holding capsules above a bowl, illustrating a step in capsule handling or preparation.*

FDA Label Image

Figure 4 (Efavirenz Fig4)

An instructional illustration showing hands holding an Efavirenz capsule above a small bowl. The image appears to demonstrate opening or handling the capsule for further processing, relevant to Efavirenz capsules provided by Aurobindo Pharma Limited in strengths of 50 mg, 100 mg, and 200 mg.*

FDA Label Image

Figure 5 (Efavirenz Fig5)

Illustration showing hands opening an Efavirenz capsule above a small bowl, with capsule contents being emptied into the bowl. This instructional diagram demonstrates how to empty the capsule for drug administration or further processing.*

FDA Label Image

Figure 6 (Efavirenz Fig6)

An instructional illustration showing two hands opening capsules and emptying their granular contents into a small bowl or container below. The image depicts how to release the capsule contents, likely for further processing or administration.*

FDA Label Image

Figure 7 (Efavirenz Fig7)

An instructional diagram showing a clock face with a shaded half and an arrow indicating 30 minutes, accompanied by the text "Finish dosing within 30 minutes," illustrating timing guidance for medication dosing.*

FDA Label Image

Figure 8 (Efavirenz Fig8)

An instructional illustration labeled as Figure H showing a hand holding a spoon above a small bowl containing powder, likely demonstrating a step in drug preparation or processing.*

FDA Label Image

Figure 9 (Efavirenz Fig9)

An instructional illustration showing an oral dosing syringe labeled with parts: barrel and plunger. The syringe is positioned next to a small round bowl. This diagram appears to demonstrate components of an oral dosing syringe used for administering liquid medication.*

FDA Label Image

Structure (Efavirenz Str)

Chemical structure diagram of efavirenz showing its molecular arrangement including a chlorine-substituted aromatic ring, a trifluoromethyl group, and a cyclopropylethynyl moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.